Certified by Founder
Lodge
Calida Therapeutics
start up
France
- Ville de Paris, Île-de-France
- 07/04/2023
- Seed
- $2,183,000
Calida Therapeutics operates as a biotechnology company. Calida Therapeutics develops monoclonal antibodies to treat and prevent thrombo-inflammatory disorders.
- Industry Biotechnology Research
- Website N/A
- LinkedIn https://www.linkedin.com/company/calida-therapeutics/
Talvy | $2,000,000 | (Mar 11, 2026)
Rhoda AI | $450,000,000 | (Mar 11, 2026)
Sigma360 | $17,000,000 | (Mar 11, 2026)
R2 Wireless | $5,000,000 | (Mar 11, 2026)
Verdant Impact | $3,000,000 | (Mar 11, 2026)
Imperium Technologies, Inc | $2,000,000 | (Mar 11, 2026)
Lux Aeterna | $10,000,000 | (Mar 11, 2026)
Amigo | $11,000,000 | (Mar 11, 2026)
Axiom Trust Company | $11,800,000 | (Mar 11, 2026)
Sandbar | $23,000,000 | (Mar 11, 2026)
Jazz | $61,000,000 | (Mar 11, 2026)
PactFi | $25,000,000 | (Mar 11, 2026)